Dr. Jason Willis, MD, PhD
drjawillis.bsky.social
Dr. Jason Willis, MD, PhD
@drjawillis.bsky.social
GI medical oncology • cancer interception • cancer genetics focused on colorectal and pancreas cancers

Expressed views or opinions are my own.
Reposted by Dr. Jason Willis, MD, PhD
There's more to advance care planning than filling out legal forms.

In our Cancerwise podcast, our experts break down the important conversations patients and caregivers should also consider having throughout the process: http://spr.ly/63325fBFt3 @rwhuey.bsky.social #EndCancer
July 19, 2025 at 2:00 PM
Reposted by Dr. Jason Willis, MD, PhD
NEW: In an unprecedented move, the NIH will soon disinvite dozens of scientists about to take positions on advisory councils that make final decisions on grant funding.

NIH staff were told to select others aligned with the Trump administration and told to expect placements by political appointees.
Exclusive: NIH to dismiss dozens of grant reviewers to align with Trump priorities
The move would undo years of work, leaving advisory councils understaffed, and without the full expertise needed for reviews.
www.nature.com
July 14, 2025 at 11:25 PM
I was honored to present this work on behalf on our phenomenal study team (led by friend and mentor Dr. Eduardo Vilar Sanchez) and LS patients.
A Phase I/II trial shows early promise in intercepting cancer in people with Lynch syndrome, our Dr. Jason Willis presented at #AACR25.

Learn more: bit.ly/4iNWGDL @drjawillis.bsky.social @theaacr.bsky.social #EndCancer
April 29, 2025 at 10:02 PM
Reposted by Dr. Jason Willis, MD, PhD
Some resources to learn more about @bsky.app, from the Public Affairs and Marketing Network (PAMN), a cooperative venture of academically based comprehensive, clinical, basic and consortium cancer centers:

ncipamn.org/having-quest... by Karen Gehrman @ucsfcancer.bsky.social
November 26, 2024 at 7:21 PM